Amino acid substitutions in gyrA and parC associated with quinolone resistance in nalidixic acid-resistant Salmonella isolates by Dong Bae et al.
Iris Tréidliachta Éireann
Bae et al. Irish Veterinary Journal 2013, 66:23
http://www.irishvetjournal.org/content/66/1/23SHORT REPORT Open AccessAmino acid substitutions in gyrA and parC
associated with quinolone resistance in nalidixic
acid-resistant Salmonella isolates
Dong Hwa Bae, Ho Jeong Baek, So Jeong Jeong and Young Ju Lee*Abstract
This study was undertaken to identify and characterize amino acid substitutions in gyrA and parC related with
quinolone resistance of 27 nalidixic acid-resistant (NaR) Salmonella isolates collected in poultry slaughterhouses in
Korea. A total of 51 Salmonella isolates were detected from 44.8% (47/105) of the total samples from 15 poultry
slaughterhouses examined, among which 27 (52.9%) NaR isolates were detected while ciprofloxacin (Cip) resistance
was not present in the isolates. These 27 NaR isolates of DNA sequencing revealed that it contained three types of
gyrA mutations in only D87 codon. Mutations in the D87 codon resulted in substitutions to G in most of the
isolates, but D87Y and D87N exchanges were also detected. Although Cip resistance was absent, reduced susceptibility
characterized by mutations in gyrA was apparent among Salmonella isolates from poultry slaughterhouses in Korea.
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Salmonellae are Gram-negative bacteria that are found
worldwide in both cold- and warm-blooded animals as
well as the environment. These bacteria are the main
cause of salmonellosis in mammals and birds. Quinolone
resistance in Salmonellae has developed over the last
three decades since the introduction of Na, the first syn-
thetic lone antimicrobial agent [1]. Several mechanisms
of quinolone resistance in Salmonella spp. have been
documented including point mutations in the quinolone
resistance-determining region (QRDR) of DNA gyrase
(gyrA and gyrB) or topoisomerase IV (parC and parE),
expression of efflux pumps on the outer membrane, and
plasmid-mediated quinolone resistance [1]. The goal of
the present study was to identify and characterize gyrA
and parC mutations associated with quinolone resist-
ance in 27 NaR Salmonella isolates collected from
poultry slaughterhouses in South Korea.Methods
A total of 51 Salmonella isolates were recovered from
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stated.chilling waters, and 75 from carcasses) collected at two
out of nine duck slaughterhouses as well as 13 out of 41
chicken slaughterhouses located in different regions of
South Korea. The first chilling water, the last chilling
water, and five carcasses from each slaughterhouse were
sampled. Bacteria were isolated from the samples ac-
cording to the standard International Standardization
Organization (ISO)-6579 method [2]. Serotyping was
performed by slide and tube agglutination using O and
H antiserum (Difco, USA) according to the Kauffmann
and White scheme [3]. If two colonies showed the same
serotypes and antimicrobial resistant patterns, only one
colony was randomly chosen for analysis in this study.
Antimicrobial resistance of all 51 Salmonella isolates
were evaluated using a disc diffusion test with the follow-
ing discs (Difco): amikacin (An, 30 μg), ampicillin (Amp,
10 μg), chloramphenicol (C, 30 μg), ceftazidime (Caz,
30 μg), cephalothin (Cf, 30 μg), ciprofloxacin (Cip, 5 μg),
cefotaxime (Ctx, 30 μg), cefazolin (Cz, 30 μg), cefepime
(Fep, 30 μg), cefoxitin (Fox, 30 μg), gentamicin (Gm,
10 μg), imipenem (Imp, 10 μg), kanamycin (K, 30 μg), nali-
dixic acid (Na, 30 μg), norfloxacin (Nor, 10 μg), strepto-
mycin (S, 10 μg), trimethoprim/sulfamethoxazole (Sxt,
1.25/23.75 μg), and tetracycline (Te, 30 μg). The results
were evaluated according to the Clinical and Laboratory. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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ATCC 25922 was used as the control strain.
All 51 Salmonella isolates from the present study were
further tested for amino acid changes in the QRDR, and
screened for the presence of the gyrA and parC genes.
Minimal inhibition concentrations (MICs) were deter-
mined for two antimicrobials, Na and Cip, belonging to
the quinolone and fluoroquinolone classes of antimicro-
bials, respectively, using an agar dilution method according
to CLSI guidelines [4].
DNA was isolated for further molecular studies using
a generation capture column kit (Qiagen, Germany) and
stored at −70°C before use. Fragments of the gyrA (F, 5′-
TGTCCGAGATGGCCTGAAGC-3′; R, 5′-TACCGT-
CATAGTTATCCACG-3′) and parC (F, 5′-CTATGCG
ATGTCAGAGCTGG-3′; R, 5′-TAACAGCAGCTCGG
CGTATT-3′) genes containing the QRDR associated
with quinolone resistance were amplified by PCR and se-
quenced as previously described [5,6]. The PCR products
were purified and sequenced by Macrogen Inc. (Daejeon,
South Korea). The nucleotide sequences were analyzed
with the Basic Local Alignment Search Tool (BLAST)
on the National Center for Biotechnology Information
(NCBI) website (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
DNA sequences of the gyrA and parC genes were com-
pared to those of native gyrA DNA (GenBank accessionTable 1 Prevalence of antimicrobial resistance in 51 Salmonel
Antimicrobials * No (%)
Enteritidis Montevideo Typhimurium Hadar
(n = 18) (n = 9) (n = 8) (n = 5)
Na 18 (100) 5 (55.6) - -
S 9 (50.0) - 1 (12.5) 5 (100)
Am 8 (44.4) - - 2 (40.0)
Te 3 (16.7) - 1 (12.5) 4 (80.0)
Cf 3 (16.7) - - 2 (40.0)
K 1 (5.6) 2 (22.2) - 2 (40.0)
Cz 1 (5.6) - - 2 (40.0)
Gm 1 (5.6) 2 (22.2) - -
C 1 (5.6) - - -
Caz 1 (5.6) - - -
Ctx 1 (5.6) - - -
Fep 1 (5.6) - - -
An - - - -
Cip - - - -
Fox - - - -
Imp - - - -
Nor - - - -
Sxt - - - -
*An, amikacin; Am, ampicillin; C, chloramphenicol; Caz, ceftazidime; Cf, cephalothin;
Gm, gentamicin; Imp, imipenem; K, kanamycin; Na, nalidixic acid; Nor, norfloxacin; Snumber X78977) and native parC DNA (GenBank ac-
cession number M68936), respectively.
Results and discussion
Resistance of the 51 Salmonella isolates to 18 antimicro-
bials is shown in Table 1. Resistance to at least one anti-
microbial was found in 74.5% (n = 38) of the isolates
while 12 isolates (23.5%) showed multi-drug resistance
to three or more classes of drug. Among the Salmonella
isolates, resistance to Na (52.9%), S (35.3%), and Am and
Te (21.6%) was frequently observed. None of the isolates
were resistant to An, Cip, Fox, Imp, Nor, or Sxt. Seven
out of eight S. Typhimurium isolates remained sus-
ceptible to all the tested antimicrobials. S. Enteritis and
S. Hadar isolates showed the highest rates of antimicro-
bial resistance in this study. Nine out of 18 S. Enteritidis
isolates were resistant to at least three antimicrobial
agents while the remaining nine isolates were resistant
to one antimicrobial compound. All five S. Hadar iso-
lates were resistant to more than two antimicrobial
agents. A previous report determined that S. Hadar is
one of the most resistant Salmonella serotypes [7].
In the present study, Na resistance (52.9%) was predom-
inant among the 51 Salmonella isolates. Twenty-seven
NaR isolates were serotyped as S. Enteritidis (n = 18), S.
Montevideo (n = 5), S. Senftenberg (n = 2), and S. Newportla isolates from poultry slaughterhouses
. of serovars Total
London Ohio Newport Senftenberg Hogton
(n = 3) (n = 3) (n = 2) (n = 2) (n = 1) (n = 51)
- - 2 (100) 2 (100) - 27 (52.9)
1 (33.3) 1 (33.3) - - 1 (100) 18 (35.3)
1 (33.3) - - - - 11 (21.6)
1 (33.3) 1 (33.3) - - 1 (100) 11 (21.6)
1 (33.3) - - - - 6 (11.8)
- - - - 1 (100) 6 (11.8)
- - - - - 3 (5.9)
- - - - - 3 (5.9)
- - - - - 1 (2.0)
- - - - - 1 (2.0)
- - - - - 1 (2.0)
- - - - - 1 (2.0)
- - - - - 0 (0.0)
- - - - - 0 (0.0)
- - - - - 0 (0.0)
- - - - - 0 (0.0)
- - - - - 0 (0.0)
- - - - - 0 (0.0)
Cip, Ciprofloxacin; Ctx, cefotaxime; Cz, cefazolin; Fep, cefepime; Fox, cefoxitin;
, streptomycin; Sxt, trimethoprim/sulfamethoxazole; Te, tetracycline.
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during the last several years in South Korea and rates of
resistance remain higher compared to those reported in
other countries. Na resistance rates among Salmonella
strains originating from chickens were found to range
from 37% to 94.3% over the last 6 years [8-12]. In contrast,
Salmonella isolates from poultry meats from several
sources in Canada were shown to lack Na resistance [13]
while very low levels of resistance were observed among
isolates from Japan (10.9%) [14] and the UK (28.2%) [15].
MICs for Na and Cip are presented in Table 2. Among
the 51 isolates, 27 (52.9%) were NaR (MIC ≥ 512 μg/mL)
while the remaining 24 (47.1%) were susceptible to Na
(MIC = 4–16 μg/mL). Interestingly, all 51 isolates were
susceptible to Cip (MIC ≤ 0.5 μg/mL). In addition, all
18 S. Enteritidis isolates collected in the present study
were highly resistant to Na (MIC ≥ 512 μg/mL) while
all eight S. Typhimurium isolates were susceptible (MIC =
8–16 μg/mL).
Table 2 shows amino acid substitutions in gyrA and
parC found in the 27 NaR isolates. These results indicateTable 2 Amino acid substitutions in gyrA and parC and antim





(No. of isolates )
Amino acid substitution in
GyrA ParC
Resistant Enteritis (18) D87G WT†
D87Y WT
D87N WT
Montevideo (5) D87G WT
Senftenberg (2) D87N WT
D87G WT
Newport (2) D87Y WT
Susceptible Typhimurium (8) WT WT
Montevideo (4) WT WT
Hadar (5) WT WT
Ohio (3) WT WT
London (3) WT WT
Hogton (1) WT WT
*D, aspartic acid; G, glycine; N, asparagine; Y, tyrosine.
†WT, wild type.
‡ Cip, ciprofloxacin; Na, nalidixic acid.
§Am, ampicillin; C, chloramphenicol; Caz, ceftazidime; Cf, cephalothin; Cz, cefazolin;
Te, tetracycline.that mutations only at position 87 in gyrA conferred
both Na resistance and Cip susceptibility. All 27 NaR
isolates possessed three different types of point muta-
tions only at position 87 in gyrA and carried a D87 to G,
Y, or N substitution. Among these 27 NaR isolates, the
most common gyrA mutation was D87G (51.9%)
followed by D87Y (37.0%) and D87N (11.1%). No muta-
tions at S83 of gyrA were observed in any isolate from
the present study. No mutation in parC that affected re-
sistance or susceptibility was identified. However, silent
mutations at V67, H75, H77, V100, D101, and G102
were found within the QRDR of parC.
Our data may confirm that the mutations at S87 of
gyrA alone can be sufficient to induce Na resistance and
Cip susceptibility. Additionally, results from the present
study imply that parC mutations are not necessary to
obtain a high level of Na resistance as hypothesized in
previous reports [16,17].
Our findings contrast with those generated by Griggs
et al. [6] and Liebana et al. [18] showing that 95.4% and
50% of Salmonella isolates from animals contained aicrobial resistance profiles in 51 Salmonella isolates from
* MICs‡ (mg/l) Antimicrobial resistance profiles§
Na Cip
512 0.25 AmCSTe (1), AmS (2), STe (1)
512 0.5 AmCfS (2), AmS (2)
>512 0.5 - (8)
>512 0.5 AmCfCzGmKCazCtxFepSTe (1), - (1)
>512 0.25 - (2)
512 0.25 - (3)
512 0.5 - (1)
512 0.25 - (1)
512 0.5 - (1)
>512 0.5 - (1)
8 <0.0625 - (6)
8 0.25 - (1)
16 <0.0625 STe (1)
4 <0.0625 GmK (2), - (2)
4 <0.0625 AmCfCzSTe (1)
8 <0.0625 AmCfCzKSTe (1), STe (2), KS (1)
4 <0.0625 STe (1), - (2)
4 <0.0625 AmCfSTe (1)
8 <0.0625 - (2)
8 <0.0625 KSTe (1)
Ctx, cefotaxime; Fep, cefepime; Gm, gentamicin; K, kanamycin; S, streptomycin;
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scribed in Salmonella isolates from humans and animals
[6], and are thought to promote resistance to Na while
reducing fluoroquinolone susceptibility.
Piddock [19] also reported that the number of quinolone-
resistant Salmonella spp. encountered in human and veter-
inary medicine is increasing. Other previous investigations
[20-22] demonstrated that a single mutation in the gyrA
gene is associated with Cip susceptibility. In contrast, parC
mutations can result in a high level of fluoroquinolone
resistance [21].
Conclusion
In conclusion, results from the present study showed
that mutations in codon D87 of the gyrA gene are suffi-
cient for conferring Na resistance and Cip susceptibility.
Our findings also suggest that mutations in codon S83
of the gyrA gene are not a main factor of Na resistance,
and parC mutations are not essential for quinolone re-
sistance. Therefore, prudent use of antimicrobials and
continued surveillance are absolutely needed to inhibit
the increasing prevalence of quinolone resistance.
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